BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 20012470)

  • 1. FOXO transcription factors and VEGF neutralizing antibody enhance antiangiogenic effects of resveratrol.
    Srivastava RK; Unterman TG; Shankar S
    Mol Cell Biochem; 2010 Apr; 337(1-2):201-12. PubMed ID: 20012470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sulforaphane inhibits angiogenesis through activation of FOXO transcription factors.
    Davis R; Singh KP; Kurzrock R; Shankar S
    Oncol Rep; 2009 Dec; 22(6):1473-8. PubMed ID: 19885601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of PI3K/AKT and MEK/ERK pathways act synergistically to enhance antiangiogenic effects of EGCG through activation of FOXO transcription factor.
    Shankar S; Chen Q; Srivastava RK
    J Mol Signal; 2008 Mar; 3():7. PubMed ID: 18355401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resveratrol induces growth arrest and apoptosis through activation of FOXO transcription factors in prostate cancer cells.
    Chen Q; Ganapathy S; Singh KP; Shankar S; Srivastava RK
    PLoS One; 2010 Dec; 5(12):e15288. PubMed ID: 21179458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of vascular endothelial growth factor-induced angiogenesis by resveratrol through interruption of Src-dependent vascular endothelial cadherin tyrosine phosphorylation.
    Lin MT; Yen ML; Lin CY; Kuo ML
    Mol Pharmacol; 2003 Nov; 64(5):1029-36. PubMed ID: 14573751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resveratrol inhibits growth of orthotopic pancreatic tumors through activation of FOXO transcription factors.
    Roy SK; Chen Q; Fu J; Shankar S; Srivastava RK
    PLoS One; 2011; 6(9):e25166. PubMed ID: 21980390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trans-3,4,5,4'-tetramethoxystilbene, a resveratrol analog, potently inhibits angiogenesis in vitro and in vivo.
    Chen LK; Qiang PF; Xu QP; Zhao YH; Dai F; Zhang L
    Acta Pharmacol Sin; 2013 Sep; 34(9):1174-82. PubMed ID: 23770989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carvedilol may attenuate liver cirrhosis by inhibiting angiogenesis through the VEGF-Src-ERK signaling pathway.
    Ding Q; Tian XG; Li Y; Wang QZ; Zhang CQ
    World J Gastroenterol; 2015 Aug; 21(32):9566-76. PubMed ID: 26327764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kaempferol inhibits angiogenic ability by targeting VEGF receptor-2 and downregulating the PI3K/AKT, MEK and ERK pathways in VEGF-stimulated human umbilical vein endothelial cells.
    Chin HK; Horng CT; Liu YS; Lu CC; Su CY; Chen PS; Chiu HY; Tsai FJ; Shieh PC; Yang JS
    Oncol Rep; 2018 May; 39(5):2351-2357. PubMed ID: 29565448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. OSU-A9 inhibits angiogenesis in human umbilical vein endothelial cells via disrupting Akt-NF-κB and MAPK signaling pathways.
    Omar HA; Arafa el-SA; Salama SA; Arab HH; Wu CH; Weng JR
    Toxicol Appl Pharmacol; 2013 Nov; 272(3):616-24. PubMed ID: 23921148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphatidylinositol inhibits vascular endothelial growth factor-A--induced migration of human umbilical vein endothelial cells.
    Matsunaga N; Shimazawa M; Otsubo K; Hara H
    J Pharmacol Sci; 2008 Jan; 106(1):128-35. PubMed ID: 18187933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Green tea polyphenol epigallocatechin gallate reduces endothelin-1 expression and secretion in vascular endothelial cells: roles for AMP-activated protein kinase, Akt, and FOXO1.
    Reiter CE; Kim JA; Quon MJ
    Endocrinology; 2010 Jan; 151(1):103-14. PubMed ID: 19887561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding of Resveratrol to Vascular Endothelial Growth Factor Suppresses Angiogenesis by Inhibiting the Receptor Signaling.
    Hu WH; Duan R; Xia YT; Xiong QP; Wang HY; Chan GK; Liu SY; Dong TT; Qin QW; Tsim KW
    J Agric Food Chem; 2019 Jan; 67(4):1127-1137. PubMed ID: 30525561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resveratrol modulates angiogenesis through the GSK3β/β-catenin/TCF-dependent pathway in human endothelial cells.
    Wang H; Zhou H; Zou Y; Liu Q; Guo C; Gao G; Shao C; Gong Y
    Biochem Pharmacol; 2010 Nov; 80(9):1386-95. PubMed ID: 20696143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-angiogenic effect of Shikonin in rheumatoid arthritis by downregulating PI3K/AKT and MAPKs signaling pathways.
    Liu C; He L; Wang J; Wang Q; Sun C; Li Y; Jia K; Wang J; Xu T; Ming R; Wang Q; Lin N
    J Ethnopharmacol; 2020 Oct; 260():113039. PubMed ID: 32497675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Piceatannol, a Natural Analog of Resveratrol, Exerts Anti-angiogenic Efficiencies by Blockage of Vascular Endothelial Growth Factor Binding to Its Receptor.
    Hu WH; Dai DK; Zheng BZ; Duan R; Dong TT; Qin QW; Tsim KW
    Molecules; 2020 Aug; 25(17):. PubMed ID: 32824997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Water extract of Korean red ginseng stimulates angiogenesis by activating the PI3K/Akt-dependent ERK1/2 and eNOS pathways in human umbilical vein endothelial cells.
    Kim YM; Namkoong S; Yun YG; Hong HD; Lee YC; Ha KS; Lee H; Kwon HJ; Kwon YG; Kim YM
    Biol Pharm Bull; 2007 Sep; 30(9):1674-9. PubMed ID: 17827719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-angiogenic effect of furanodiene on HUVECs in vitro and on zebrafish in vivo.
    Zhong ZF; Hoi PM; Wu GS; Xu ZT; Tan W; Chen XP; Cui L; Wu T; Wang YT
    J Ethnopharmacol; 2012 Jun; 141(2):721-7. PubMed ID: 21911050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salinomycin exhibits anti-angiogenic activity against human glioma in vitro and in vivo by suppressing the VEGF-VEGFR2-AKT/FAK signaling axis.
    Bi YL; Mi PY; Zhao SJ; Pan HM; Li HJ; Liu F; Shao LR; Zhang HF; Zhang P; Jiang SL
    Int J Mol Med; 2017 May; 39(5):1255-1261. PubMed ID: 28358414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Placental growth factor neutralising antibodies give limited anti-angiogenic effects in an in vitro organotypic angiogenesis model.
    Brave SR; Eberlein C; Shibuya M; Wedge SR; Barry ST
    Angiogenesis; 2010 Dec; 13(4):337-47. PubMed ID: 20953695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.